Emil Kuriakose

CHIEF MEDICAL OFFICER, Calithera Biosciences, Inc.

Companies

Terns Pharmaceuticals, Inc.Chief Medical Officer Mar 19, 2024 to now¹
Calithera Biosciences, Inc.CHIEF MEDICAL OFFICER Nov 9, 2021 to Jan 25, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 5, 2026Returned to company 81,953 shares at $53.00 of Terns Pharmaceuticals, Inc.⁴
May 5, 2026U 24,562 shares at $53.00 of Terns Pharmaceuticals, Inc.⁴
Apr 1, 2026Sold 942 shares at $52.75 of Terns Pharmaceuticals, Inc.⁵
Jan 14, 2026Granted 56,250 shares of Terns Pharmaceuticals, Inc.⁶
Jan 2, 2026Sold 955 shares at $38.36 of Terns Pharmaceuticals, Inc.⁷
Jan 2, 2026Sold 200 shares at $39.60 of Terns Pharmaceuticals, Inc.⁷
Oct 1, 2025Sold 944 shares at $7.85 of Terns Pharmaceuticals, Inc.⁸
Jul 1, 2025Sold 853 shares at $4.27 of Terns Pharmaceuticals, Inc.⁹
Apr 1, 2025Sold 952 shares at $2.49 of Terns Pharmaceuticals, Inc.¹⁰
Jan 2, 2025Sold 4,481 shares at $5.71 of Terns Pharmaceuticals, Inc.¹¹
Jan 23, 2023Shares withheld for tax 79 shares at $0.45 of Calithera Biosciences, Inc.³
Jan 21, 2022Shares withheld for tax 666 shares at $0.49 of Calithera Biosciences, Inc.¹²
Jan 4, 2022Shares withheld for tax 3,855 shares at $0.66 of Calithera Biosciences, Inc.¹³
Nov 8, 2021Shares withheld for tax 3,077 shares at $0.87 of Calithera Biosciences, Inc.¹⁴
Nov 5, 2021Granted 12,000 shares of Calithera Biosciences, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.